Photoinduced cytotoxicity and biodistribution of prostate cancer cell-targeted porphyrins

被引:56
|
作者
Sehgal, Inder [1 ]
Sibrian-Vazquez, Martha
Vicente, M. Graca H.
机构
[1] Louisiana State Univ, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA
基金
美国国家科学基金会;
关键词
D O I
10.1021/jm800444c
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of five porphyrin-peptide conjugates bearing one or two sequences containing a cell penetrating peptide (CPP), a nuclear localization signal (NLS), or a bifunctional CPP-NLS or NLS-CPP sequences were synthesized and investigated in vitro using PC-3M human prostate cancer cells, in comparison with FDA-approved purified hematoporphyrin derivative (Porfimer Sodium) and mTHPC. The most promising porphyrin-HIV-1 Tat (48-60) conjugate 2 [lowest dark cytotoxicity (IC(50) = 38.0 mu M), highest phototoxicity (IC(50) = 0.40 mu M at 1 J/cm(2))] was further evaluated in an in vivo biodistribution study using SCID mice bearing PC-3M tumors, in comparison with purified hematoporphyrin derivative. Porphyrin conjugate 2 was more tumor selective than the hematoporphyrin derivative and accumulated to a significantly greater extent in tumors. Our results show that effective photodynamic cytotoxicity can be induced in human prostate cancer cells with minimal dark toxicity and that selective accumulation in prostate tumors can be achieved in vivo with porphyrin-targeted photosensitizers.
引用
收藏
页码:6014 / 6020
页数:7
相关论文
共 50 条
  • [1] The Dark Side of Mast Cell-Targeted Therapy in Prostate Cancer
    Pittoni, Paola
    Colombo, Mario Paolo
    [J]. CANCER RESEARCH, 2012, 72 (04) : 831 - 835
  • [2] Synthesis of KUE-siRNA Conjugates for Prostate Cancer Cell-Targeted Gene Silencing
    Yang, Chao
    Ma, Dejun
    Lu, Liqing
    Yang, Xing
    Xi, Zhen
    [J]. CHEMBIOCHEM, 2021, 22 (19) : 2888 - 2895
  • [3] Mast Cell-Targeted Strategies in Cancer Therapy
    Ammendola, Michele
    Sacco, Rosario
    Sammarco, Giuseppe
    Luposella, Maria
    Patruno, Rosa
    Gadaleta, Cosmo Damiano
    De Sarro, Giovambattista
    Ranieri, Girolanno
    [J]. TRANSFUSION MEDICINE AND HEMOTHERAPY, 2016, 43 (02) : 109 - 113
  • [4] Multifunctional Bioconjugate for Cancer Cell-Targeted Theranostics
    Du, Wei
    Yuan, Yue
    Wang, Lin
    Cui, Yusi
    Wang, Hui
    Xu, Huiqin
    Liang, Gaolin
    [J]. BIOCONJUGATE CHEMISTRY, 2015, 26 (12) : 2571 - 2578
  • [5] Natural Killer Cell-targeted Immunotherapy for Cancer
    Tang, Jingyi
    Zhu, Qi
    Li, Zhaoyang
    Yang, Jiahui
    Lai, Yu
    [J]. CURRENT STEM CELL RESEARCH & THERAPY, 2022, 17 (06) : 513 - 526
  • [6] Recent Advances in Cancer Stem Cell-Targeted Immunotherapy
    Badrinath, Narayanasamy
    Yoo, So Young
    [J]. CANCERS, 2019, 11 (03):
  • [7] Cancer stem cell-targeted therapeutics and delivery strategies
    Ahmad, Gulzar
    Amiji, Mansoor M.
    [J]. EXPERT OPINION ON DRUG DELIVERY, 2017, 14 (08) : 997 - 1008
  • [8] Mathematical modelling of cancer stem cell-targeted immunotherapy
    Sigal, Daniel
    Przedborski, Michelle
    Sivaloganathan, Darshan
    Kohandel, Mohammad
    [J]. MATHEMATICAL BIOSCIENCES, 2019, 318
  • [9] Chimeric aptamers in cancer cell-targeted drug delivery
    Kanwar, Jagat R.
    Roy, Kislay
    Kanwar, Rupinder K.
    [J]. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2011, 46 (06) : 459 - 477
  • [10] Multiarm Nanoconjugates for Cancer Cell-Targeted Delivery of Photosensitizers
    Zhao, Yan
    Li, Fang
    Mao, Chengqiong
    Ming, Xin
    [J]. MOLECULAR PHARMACEUTICS, 2018, 15 (07) : 2559 - 2569